|
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits Clinical research trials and A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits. A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits clinical trial. Test subjects typically obtain the finest healthcare available for their A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits  A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
For Condition: Schizophrenia
Status: Recruiting
Sponsor(s): Johnson & Johnson Pharmaceutical Research and Development, L.L.C. ,
Synopsis: This is an exploratory study which will evaluate Galantamine in cognitive deficits (learning) in patients with schizophrenia. The trial will last for 8 weeks. Efficacy and safety will be studied. The patients must be on a stable dose of an antipsychotic and smoke cigarettes.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/55 Years
Genders: Both
Protocol Entry Criteria: - Patient must be on a stable atypical antipsychotic for at least 30 days - Women of child bearing potential must use approved method of birth control - Patients must smoke at least 5 cigarettes per day - Patient cannot have major medical problems
Total Enrollment: 100
Location and Contact Information:
Health Sciences Center *Recruiting*
Winnipeg, Manitoba, R3E 3N4
Canada
Recruiting Brendon Foot 204-787-3246
Psychopharmcology Research Unit *Recruiting*
Edmonton, Alberta, T6G 2B7
Canada
Recruiting Rawle Carter 780-407-1589
Foothills Medical Center *Recruiting*
Calgary, Alberta, T2N T9
Canada
Recruiting Geri Anderson 403-944-1050
Providence Continuing Care Center *Recruiting*
Kingston, Ontario, K7L 4X3
Canada
Recruiting Ann Shea 613-548-5567
Royale Ottawa Hospital *Recruiting*
Ottawa, Ontario, K17 7K4
Canada
Recruiting Sandhya Patel 613-722-6521
Additional Information:
Study ID Numbers: GAL-SCH-201;
Study Start Date: May 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00077727
Other Schizophrenia Studies:
1. Rehabilitative Training for Older People with Schizophrenia
2. Safety and efficacy of study drug versus placebo for negative symptoms of schizophrenia
3. Comparison of Risperidone and Aripiprazole for Childhood-Onset Psychotic Disorders
4. Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers
5. Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia
Related Studies:
Other Schizophrenia Clinical Trials
Other Ontario Clinical Trials
Other Kingston Clinical Trials
A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
|
|
|
|
|
|
|
|
